Contrast Media Market Analysis by Key Players, Trends, Insights, Dynamics, Outlook, Applications, SWOT Analysis, Profile, Growth and Segmentation, Forecast to 2023. According to the latest report published by Market Research Future (MRFR), the contrast media market will grow extensively throughout the forecast period with a CAGR of 6.3%. The threats associated with the rise in the number of patients suffering from chronic diseases are propelling growth in the contrast media market.
The major driver of the contrast media market acceleration is the wide range of imaging tests that fuel the demand for contrast media. The imaging tests such as Magnetic Resonance Imaging (MRI), x-rays, Computed Tomography (CT), etc. have become an inevitable part of the diagnosis for most of the diseases. The large-scale penetration of imaging technology in healthcare has catalyzed the demand for contrast media in the market. The incidences of cardiovascular diseases, cancer, etc. have been on a steep rise which creates a need for the availability of better healthcare imaging tests. In 2012, the U.S. witnessed an inclusion of 14.1 Million new cancer patients with the death count of cancer patients reaching a mark of 8.2 Million.
Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/1284
Global Contrast Media Market Segmentation:
By type, the contrast media market has been segmented into intravenous contrast materials, iodine-based, and, other.
By procedures, the contrast media market has been segmented into X-ray, computed tomography, magnetic resonance imaging, ultrasound, and, other.
By application, the global contrast media market has been segmented into X-ray, computed tomography, magnetic resonance imaging, ultrasound, and, other.
Contrast Media Market Competitive Dashboard:
Some of the key players of the market have been profiled by MRFR in its report for a detailed understanding of the market, they are GE Healthcare (US), Bayer Healthcare Pharmaceuticals (Germany), NanoScan Imaging (US), Targeson (US), Bracco Diagnostic Inc. (Italy), Covidien (Ireland), Bracco Imaging S.p.A. (Italy), CMC Contrast AB (Sweden), Mallinckrodt Pharmaceuticals (UK), Daiichi (Japan), AMAG Pharmaceuticals (US), Medrad Inc (US), Guerbet (Japan), Guerbet Group (France), Lantheus Medical Imaging (U.S.), Subhra Pharma Private Limited (India), and, nanoPET Pharma GmbH (Germany).
Browse Full Report Details at: https://www.marketresearchfuture.com/reports/contrast-media-market-1284
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +16468459312
Email: sales@marketresearchfuture.com
